# Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD)

> **NCT00685126** · PHASE3 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 117 (actual)

## Conditions studied

- Reactive Airways Disease (RAD)

## Interventions

- **DRUG:** Levalbuterol HCl Inhalation Solution
- **DRUG:** Levalbuterol HCl Inhalation Solution
- **DRUG:** Albuterol HCl Inhalation Solution

## Key facts

- **NCT ID:** NCT00685126
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2002-07
- **Final completion:** 2002-07
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00685126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00685126, "Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD)". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00685126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*